Just spotted an interesting insider trade at QuidelOrtho. One of their board directors, Matthew Strobeck, dropped about $240k to grab 10,000 shares back in mid-February at around $23.96 each. What caught my eye is the breakdown of his holdings - he's got 27,775 shares in direct ownership now, but also holds another 54,775 shares indirectly through UGMA accounts and something called Birchview Fund, LLC. So his total stake is sitting at roughly 82,550 shares across both direct and indirect positions.

Here's the thing though - QDEL has been getting hammered. The stock is down over 44% in the past year and has dropped another 23% just since the start of 2026. The company reported Q4 earnings recently and it's the third straight year of declining revenue and operating losses. On top of that, their CFO Joseph Busky just announced he's retiring, so they've got until June to find a replacement. This is coming right after they had major leadership changes and layoffs a couple years back.

When a board director is buying shares despite all this bad news, you have to wonder if he sees something others don't. Or maybe he's just showing confidence in a turnaround. Either way, it's worth keeping an eye on. The fact that he's maintaining his UGMA accounts and other indirect holdings unchanged while adding direct shares suggests he's not making any major portfolio restructuring - just adding to his direct stake. Could be a signal, could be nothing, but definitely interesting timing for an insider purchase.